Orikine Bio

Developer of therapeutics for the treatment of immune-mediated diseases

placeBarcelona, Catalonia, Spain calendar_todayFounded 2022 language orikine.bio

Social engagement

Social engagement: 2.3K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital267%
Other / undisclosed133%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

3 Mar 2026 · Immunology Research Scientist

Based on job postings tracked across public sources.

Recent activity

23 Jun 2026
Leadership hire
Chief Scientific Officer and Chief Development Officer
10 Jun 2026
Event
BIO International Convention 2026
17 Apr 2026
Milestone
regulatory
Coming soon